Paper41007052
Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets.
Gvozdeva Y and 1 other. Children (Basel), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets. Papers, record 41007052. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007052
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34822316 | Orodispersible tablets for pediatric drug delivery: current challenges and recent advances. | Expert Opin Drug Deliv | 2021 | https://conductscience.org/library/papers/34822316 | PubMed |
| 2 | 28040560 | A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice. | Int J Pharm | 2017 | https://conductscience.org/library/papers/28040560 | PubMed |
| 3 | 34371705 | Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34371705 | PubMed |
| 4 | 25854872 | Potentially harmful excipients in neonatal medicines: a pan-European observational study. | Arch Dis Child | 2015 | https://conductscience.org/library/papers/25854872 | PubMed |
| 5 | 22883696 | WHO guideline development of paediatric medicines: points to consider in pharmaceutical development. | Int J Pharm | 2012 | https://conductscience.org/library/papers/22883696 | PubMed |
| 6 | 35204916 | A Survey to Understand Parent/Caregiver and Children's Views on Devices Used for the Administration of Oral Pediatric Medicines in Japan. | Children (Basel) | 2022 | https://conductscience.org/library/papers/35204916 | PubMed |
| 7 | 27863675 | Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study. | Int J Pharm | 2016 | https://conductscience.org/library/papers/27863675 | PubMed |
| 8 | 25736528 | Orodispersible drug formulations for children and elderly. | Eur J Pharm Sci | 2015 | https://conductscience.org/library/papers/25736528 | PubMed |
| 9 | 38258129 | Potentially Harmful Excipients: State of the Art for Oral Liquid Forms Used in Neonatology and Pediatrics Units. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38258129 | PubMed |
| 10 | 32992469 | Paediatric Formulation: Design and Development. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32992469 | PubMed |
| 11 | 24070789 | The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version. | Int J Pharm | 2013 | https://conductscience.org/library/papers/24070789 | PubMed |
| 12 | 19149727 | Trends in pharmaceutical taste masking technologies: a patent review. | Recent Pat Drug Deliv Formul | 2009 | https://conductscience.org/library/papers/19149727 | PubMed |
| 13 | 37689320 | Survey-based investigation into the current use of paediatric medicines and administration devices in China. | Eur J Pharm Biopharm | 2023 | https://conductscience.org/library/papers/37689320 | PubMed |
| 14 | 28225679 | Pediatric Drug Formulations - Unintended Consequences of Legislation. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28225679 | PubMed |
| 15 | 30837807 | Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety. | J Pediatr Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30837807 | PubMed |
| 16 | 27270905 | Paediatric Drug Development and Formulation Design-a European Perspective. | AAPS PharmSciTech | 2017 | https://conductscience.org/library/papers/27270905 | PubMed |
| 17 | 35056165 | Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35056165 | PubMed |
| 18 | 32265601 | Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. | J Pediatr Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32265601 | PubMed |
| 19 | 28250539 | Medicines for children: flexible solid oral formulations. | Bull World Health Organ | 2017 | https://conductscience.org/library/papers/28250539 | PubMed |
| 20 | 31597277 | Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31597277 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007052
GET https://conductscience.org/api/papers/v1/41007052/references?page=2